Bend Research Improves Speed-to-Clinic Capability for Oral and Inhalation Formulation Development

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BEND, Ore.--(BUSINESS WIRE)--Bend Research Inc., part of Capsugel’s Dosage Form Solutions business unit, announced the addition of Capsugel’s Xcelodose® precision powder-filling technology to its drug development process. This patented micro-dosing technology will further enhance Bend Research’s recently announced Rapid Advancement of Preclinical Compounds initiative. The technology will also facilitate fast and efficient scale up and transfer of powder-fill formulations within Capsugel’s global network of commercial production sites.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC